If you'd invested in: Renishaw and GlaxoSmithKline

Measuring-equipment maker Renishaw has seen profits leap, but investors are sceptical about the prospects for drugmaker GSK.

If only...

885_Good

Renishaw (LSE:RSW) develops and sells high-technology precision measuring and calibration equipment. Over the past 12 months, it almost doubled its market value as results continue to impress. Revenues jumped 17% to £279.5m, while adjusted pre-tax profit leapt 72% higher to £62.3m. It now expects full-year revenues to cross the £600m mark for the first time. However, the shares slipped back in January when David McMurtry the firm's founder, largest shareholder, chairman and chief executive announced he was stepping down as chief executive.

Be glad you didn't

885_Bad

GlaxoSmithKline (LSE:GSK) is Britain's biggest drugmaker. Last July the company said it would offload more than 130 of its non-core brands as it extended a restructuring programme meant to deliver £1bn in annual cost savings by 2020. In October, the chief executive, Emma Walmsley who took over last April announced a 4% rise in third-quarter sales to £7.8bn, helped by demand for new HIV, lung and meningitis products. Operating profit rose 31% to £1.9bn. But investors remain sceptical about the sustainability of the firm's dividend and the shares slid further.

Recommended

Share tips of the week
Share tips

Share tips of the week

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
17 Jan 2020
How the fear of death affects our investment processes
Investment strategy

How the fear of death affects our investment processes

Many of our investment decisions are driven by one simple fact: the knowledge that, one day, we will be dead. Here, in an extract from his new book, J…
2 Jan 2020
Share tips: eight stocks that should deliver robust returns
Share tips

Share tips: eight stocks that should deliver robust returns

Ryan Ermey of US publication Kiplinger’s Personal Finance chooses his favourite stocks for the next decade, which should be able to grow for years.
28 Dec 2019
The good investments of the 2010s – and the bad
Stockmarkets

The good investments of the 2010s – and the bad

John Stepek takes a look back on which investments did well and which did badly in the decade that’s about to come to an end.
26 Dec 2019

Most Popular

No, the UK did not “plunge” into recession yesterday
UK Economy

No, the UK did not “plunge” into recession yesterday

That the economy took a massive hit due to Covid-19 should be news to no one, says John Stepek. The real question is what happens now.
13 Aug 2020
Inflation spiked in the US last month – is this the shape of things to come?
US Economy

Inflation spiked in the US last month – is this the shape of things to come?

Prices in the US rose much more dramatically than expected in July. Can we expect more of the same, and what does that mean for your money? John Stepe…
14 Aug 2020
The MoneyWeek Podcast: house prices, staycations, and the death of cash
House prices

The MoneyWeek Podcast: house prices, staycations, and the death of cash

John and Merryn talk about the rise in UK house prices and the fact that everybody is holidaying in the UK, plus gold's new highs, the death of cash, …
12 Aug 2020